Bristol Myers Squibb reported $2.1B in Stock for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Abbott ABT:US $ 5691M 534M
Abbvie ABBV:US $ 3483M 355M
ALKERMES ALKS:US $ 154.79M 4.45M
Amgen AMGN:US $ 4411M 325M
Biogen BIIB:US $ 1215.4M 136.1M
Bristol Myers Squibb BMY:US $ 2104M 9M
Catalent CTLT:US $ 697M 9M
Eli Lilly And LLY:US $ 3893M 7M
Endo International Ordinary Shares ENDP:US $ 283.83M 0.27M
Gilead Sciences GILD:US $ 2675M 1057M
GlaxoSmithKline GSK:LN 6003M 220M
JAZZ PHA JAZZ:US $ 985.45M 87.27M
Johnson & Johnson JNJ:US $ 10990M 603M
Lannett LCI:US $ 95.43M 10.34M
Medtronic MDT:US $ 4616M 102M
Merk MRK:US $ 5774M 179M
Novartis NOVN:VX SF 6997M 331M
Perrigo Ordinary Shares PRGO:US $ 1022.4M 2.2M
Pfizer PFE:US $ 9979M 920M
Phibro Animal Health PAHC:US $ 249.91M 19.13M
Prestige Brands PBH:US $ 120.34M 14.07M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Revance Therapeutics RVNC:US $ 10.66M 0.5M
Teva Pharmaceutical Industries TEVA:US $ 4012M 194M
United Therapeutics UTHR:US $ 88.2M 5.6M
Zoetis ZTS:US $ 2057M 134M